ライフサイエンスコーパス: hip fracture

1 perienced a first fracture at any site (3871 hip fractures).

2 shows a weakly positive protective trend for hip fracture.

3 completed traditional rehabilitation after a hip fracture.

4 -term functional limitations persist after a hip fracture.

5 ienced fracture of any type, and 3,871 had a hip fracture.

6 rs of follow-up, 95 men (1.7%) experienced a hip fracture.

7 ignificantly increased risk for both MOF and hip fracture.

8 ry in patients who had undergone surgery for hip fracture.

9 ibit gastric acid might increase the risk of hip fracture.

10 CT for suspicion of a nondisplaced traumatic hip fracture.

11 sons with at least one other risk factor for hip fracture.

12 hromboembolism and stroke and a reduction in hip fracture.

13 h a diagnosis of PA have an elevated risk of hip fracture.

14 pancreatectomy, esophagectomy, and repair of hip fracture.

15 hormone therapy had the lowest incidence of hip fracture.

16 5% CI, 0.45-0.99, P = .05) for patients with hip fracture.

17 re these declines in functional status after hip fracture.

18 ive therapies and who had not had a previous hip fracture.

19 ations are associated with a higher risk for hip fracture.

20 rs was not associated with increased risk of hip fracture.

21 uch policies have decreased the incidence of hip fracture.

22 ed within 90 days after surgical repair of a hip fracture.

23 t score was developed for the probability of hip fracture.

24 The primary outcome was incident hip fracture.

25 ge, and 1, 3, 6, 12, 18, 24 months following hip fracture.

26 ars at baseline in 1994-2003) with regard to hip fracture.

27 I; weight (kg)/height (m)(2)) lowers risk of hip fracture.

28 .4 years, 1,603 women and 951 men suffered a hip fracture.

29 c fracture, and of these, 129 (10.9%) were a hip fracture.

30 feasible, and could be effective in reducing hip fractures.

31 he relation of soda consumption with risk of hip fractures.

32 y of follow-up, we identified 1873 incident hip fractures.

33 whether these effects are driven largely by hip fractures.

34 MAIN OUTCOME MEASURES: One-year incidence of hip fractures.

35 s justifiable in patients at higher risk for hip fractures.

36 showed no association with relative risk of hip fractures.

37 condary end points included nonvertebral and hip fractures.

38 and study population for both vertebral and hip fractures.

39 ndisplaced hip fractures and 96 did not have hip fractures.

40 atic major osteoporotic fractures (MOFs) and hip fractures.

41 loped incident fractures, including 198 with hip fractures.

42 183), but screening reduced the incidence of hip fractures (0.72, 0.59-0.89, p=0.002).

43 teoporotic fractures: 0.90 (0.83, 0.96); for hip fractures: 0.85 (0.81, 0.89) per z score of dietary

44 5 +/- 5.25 vs. 5.50 +/- 5.52; P < 0.001) and hip fractures (1.57 +/- 2.40 vs. 1.79 +/- 2.69; P = 0.00

45 F, 1.15; 95% CI, 1.04-1.26; P < .05; aHR for hip fracture, 1.24; 95% CI, 1.05-1.47; P < .05) were eac

46 F, 1.43; 95% CI, 1.27-1.60; P < .05; aHR for hip fracture, 1.48; 95% CI, 1.18-1.85; P < .05), antipsy

47 teoporotic fractures: 1.08 (1.00, 1.06); for hip fractures: 1.06 (1.02, 1.12) per z score].

48 s (27 per 1000 individuals) were lost due to hip fractures, 1230 (20.6%) of which were in the group a

49 Defining events included 137 hip fractures, 186 myocardial infarctions, 335 incidence

50 F, 1.43; 95% CI, 1.15-1.77; P < .05; aHR for hip fracture, 2.14; 95% CI, 1.52-3.02; P < .05), and ben

51 4 clinical trials with separate results for hip fracture (6,504 subjects with 139 hip fractures), th

52 tive risk [RR], 0.91; 95% CI, 0.86-0.96) and hip fractures (absolute risk, 0.8 vs 1.0 per 100 person-

53 e the association between BMI and subsequent hip fracture according to sex and age and 2) to explore

54 ed in women identified to be at high risk of hip fracture, according to the FRAX 10-year hip fracture

55 odiazepine prescribing and hazard ratios for hip fracture, adjusted for age and eligibility category.

56 ent subgroups that experienced lower odds of hip fracture after cataract surgery included patients wi

57 andomly assigned home-dwelling patients with hip-fractures aged 70 years or older who were able to wa

58 [aHR], 1.39; 95% CI, 1.27-1.51; P < .05) and hip fracture (aHR, 1.43; 95% CI, 1.22-1.69; P < .05) bef

59 ) and falls, 10-year cumulative incidence of hip fracture alone, and nonvertebral fracture incidence

60 y designed, are not effective for preventing hip fracture among nursing home residents.

61 may be useful to predict the 5-year risk of hip fracture among postmenopausal women of various ethni

62 There were 495 postbaseline hip fractures among 5,511 respondents aged >or=69 years.

63 (95% confidence interval (CI): 1.3, 1.7) for hip fracture and 1.4 (95% CI: 1.2, 1.6) for other fall-r

64 95% confidence interval [CI], 1.43-2.48) for hip fracture and 1.52 (95% CI, 1.31-1.75) for nonspine f

65 ars, 76 participants experienced an incident hip fracture and 113 participants experienced a major os

66 Of 1199 men with DM, 32 experienced a hip fracture and 133 a nonspine fracture during a mean (

67 en with DM were 5.71 (95% CI, 3.42-9.53) for hip fracture and 2.17 (95% CI, 1.75-2.69) for nonspine f

68 Of 770 women with DM, 84 experienced a hip fracture and 262 a nonspine fracture during a mean (

69 was somewhat favorable in the prevention of hip fracture and any nonvertebral fracture in persons 65

70 Hazard ratios for hip fracture and associated 95% confidence intervals wer

71 iderably greater after hospitalization for a hip fracture and other fall-related injury than for a no

72 study the association between s-retinol and hip fracture and whether high s-retinol may counteract a

73 ity studies were 1.12 (CI, 0.83 to 1.51) for hip fractures and 1.04 (CI, 0.76 to 1.42) for nonspine f

74 e 7 cohorts were 1.26 (CI, 0.96 to 1.65) for hip fractures and 1.16 (CI, 0.95 to 1.42) for nonspine f

75 yrodism were 1.38 (95% CI, 0.92 to 2.07) for hip fractures and 1.20 (CI, 0.83 to 1.72) for nonspine f

76 rthyroidism were 2.16 (CI, 0.87 to 5.37) for hip fractures and 1.43 (CI, 0.73 to 2.78) for nonspine f

77 age, 76 years; 91% women) with 1111 incident hip fractures and 3770 nonvertebral fractures.

78 Results Twenty-two patients had nondisplaced hip fractures and 96 did not have hip fractures.

79 for the detection of nondisplaced traumatic hip fractures and improved diagnostic confidence in the

80 cium images in the detection of nondisplaced hip fractures and to assess whether obtaining these imag

81 2 hospitalizations for an injurious fall (59 hip-fracture and 63 other fall-related injuries) to 241

82 other conditions leading to hospitalization, hip-fracture and other fall-related injuries are associa

83 For both hip-fracture and other fall-related injuries, the disabi

84 -0.86) for CHF, 0.74 (95% CI, 0.68-0.80) for hip fracture, and 0.78 (95% CI, 0.66-0.91) for colon can

85 MI, 10.2% vs 12.4% for CHF, 7.7% vs 9.7% for hip fracture, and 3.3% vs 3.9% for CHF; fully adjusted r

86 ident MOF, 1579 (2.3%) sustained an incident hip fracture, and 8998 (13.1%) died.

87 lism, endometrial cancer, colorectal cancer, hip fracture, and death due to other causes.

88 lism, colorectal cancer, endometrial cancer, hip fracture, and death.

89 lung cancer, pneumonia, pulmonary embolism, hip fracture, and depression for all participants.

90 , acute stroke, gastrointestinal hemorrhage, hip fracture, and pneumonia-patient admission to hig her

91 Mortality is increased after a hip fracture, and strategies that improve outcomes are n

92 have higher mortality rates than women after hip fracture, and that men may experience fractures at h

93 and urinary morbidity, erectile dysfunction, hip fractures, and additional cancer therapy.

94 , chronic renal failure, RRT, all fractures, hip fractures, and vertebral fractures occurred in 0.6%,

95 ortions of participants who had at least one hip fracture, any clinical fracture, or mortality; and t

96 onsumption of dairy products and the risk of hip fracture are less well established, although yogurt

97 Most patients with hip fractures are characterised by older age (>70 years)

98 (6 months and 24 months), were restricted to hip fracture as the outcome, and were completed in vario

99 5% confidence interval (CI): 1.18, 1.60) for hip fracture, as compared with women with BMI 22-24.9; a

100 used to determine the hazard ratio (HR) for hip fracture associated with PA.

101 followed for fracture, the absolute risk for hip fracture at 10 years was 20.4 events per 1000 patien

102 ars or older who were undergoing surgery for hip fracture at general acute care hospitals in New York

103 included the incidences of nonvertebral and hip fracture at the time of the primary analysis.

104 with BMD tests and self-reports of parental hip fracture between 2006 and 2014.

105 the risk factor responsible for the greatest hip fracture burden (7.5%, 95% CI 5.2-9.7) followed by p

106 ilar for venous thromboembolism, stroke, and hip fracture but also included evidence of longer-term e

107 th less gastrointestinal morbidity and fewer hip fractures but more erectile dysfunction; IMRT compar

108 Nucleotide analogs may increase the risk of hip fracture, but the overall event rate is low.

109 This proof-of-concept study focused on hip fractures, but use of record linkage techniques to v

110 of participants reclassified as high risk of hip fracture by 3.9% (95% CI, -2.2% to 9.9%), whereas it

111 imated the 10-year risk of MOF by 29% and of hip fracture by 51% for those with depression.

112 FRAX underestimated the 10-year risk of hip fracture by 57% for use of selective serotonin reupt

113 We computed RRs for hip fractures by the amount of soda consumption by using

114 INTERPRETATION: Hip fracture can lead to a substantial loss of healthy l

115 common, particularly among older women, and hip fractures can be devastating.

116 stored serum was available in 1154 incident hip fracture cases with valid body mass index (BMI) data

117 Hip fracture characteristics, socioeconomic status, and

118 ratio [HR] [95% confidence interval; CI]) of hip fracture, compared to HCV-monoinfected (HR, 1.38; 95

119 ction was associated with increased rates of hip fracture, compared to HCV-monoinfected, HIV-monoinfe

120 ion was associated with an increased risk of hip fracture, compared to uninfected individuals, and th

121 CV infection alone are at increased risk for hip fracture, compared to uninfected individuals, and to

122 noinfected patients had an increased risk of hip fracture, compared to uninfected individuals.

123 amined were other secondary events including hip fractures, congestive heart failure, angina, falls,

124 ory of fracture after age 54 years, parental hip fracture, current smoking, current corticosteroid us

125 r, colorectal cancer, endometrial cancer, or hip fracture; death from other causes; a summary global

126 Pelvis/hip fractures declined slightly from 29.6 to 20.6 per 10

127 to detect a protective effect on the risk of hip fracture, despite good adherence to protocol.

128 ry incontinence; benefits included decreased hip fractures, diabetes, and vasomotor symptoms.

129 the inclusion criteria; 13.6% had a parental hip fracture diagnosis in administrative data during an

130 onger interval between BMD test and parental hip fracture diagnosis.

131 The association between soda and hip fractures did not differ by body mass index or diagn

132 were 13,976 patients (1.3%) who sustained a hip fracture during the study period.

133 ferent countries show variations of a shared hip fracture epidemic.

134 also detected significant associations with hip fracture for ADAMTS18 SNPs in the Chinese HF sample.

135 ed 7076 men 45 years and older with incident hip fracture from 1997-2006.

136 e relative risks (RRs) of first incidence of hip fracture from low-trauma events per glass (8 fl oz o

137 Agreement between parental hip fracture from offspring reports and diagnoses in adm

138 Patients undergoing surgery for a hip fracture have a higher risk of mortality and major c

139 per SD decrease was associated with risk of hip fracture (hazard ratio [HR], 1.43 [95% CI, 1.16 to 1

140 .99; 95% confidence interval: 0.98, 1.00) or hip fracture (hazard ratio per 200 mL coffee = 0.97, 95%

141 o 2000), with a 30% reduction in the risk of hip fracture (hazard ratio, 0.70; 95% CI, 0.58 to 0.86)

142 nonsignificant 10% reduction in the risk of hip fracture (hazard ratio, 0.90; 95% confidence interva

143 0.14% and 0.12%, respectively) experienced a hip fracture (hazard ratio: 1.12; 95% CI: 0.94, 1.34; P

144 ite U.S. families (1972 subjects), a Chinese hip fracture (HF) sample (350 cases, 350 controls), a Ch

145 acid is associated with an increased risk of hip fracture; however, this association was only found a

146 th nucleoside analogs, increased the risk of hip fracture (HR = 5.69; 95% confidence interval: 1.98-1

147 fracture (HR: 0.66; 95% CI: 0.45, 0.95), and hip fracture (HR: 0.58; 95% CI: 0.36, 0.95).

148 nt use was associated with a reduced rate of hip fracture (HR: 0.78; 95% CI: 0.65, 0.93) and any frac

149 l fracture (HR: 0.99; 95% CI: 0.97, 1.02) or hip fracture (HR: 0.91; 95% CI: 0.84, 1.00), but there w

150 s 1-4) were associated with a higher rate of hip fracture (HR: 3.33; 95% CI: 1.43, 7.76) and any frac

151 intile 4 having significantly lower risks of hip fractures (HR: 0.35; 95% CI: 0.16, 0.80) and spine f

152 -0.86; P = .03), whereas among patients with hip fracture, implementation was associated with increas

153 ndronate was associated with a lower risk of hip fracture in a multivariable-adjusted Cox model (haza

154 the validity of offspring-reported parental hip fracture in a unique bone mineral density (BMD) regi

155 The 10-year cumulative incidence of hip fracture in all recipients was 1.7% (>/=3% defined a

156 tion is associated with a lower incidence of hip fracture in Asian than in Western women, an effect o

157 ociated with a significant 9% higher risk of hip fracture in men (RR = 1.09; 95% CI, 1.01-1.17).

158 The HR for hip fracture in men for each 1-SD decrease in serum alph

159 ears was not associated with a lower risk of hip fracture in older adults.

160 en usual physical activity level and rate of hip fracture in older men or applied semiparametric meth

161 tective effect of usual physical activity on hip fracture in older men.

162 e efficacy of alendronate to protect against hip fracture in older patients using glucocorticoids.

163 m of this study was to determine the risk of hip fracture in patients with PA.

164 ncluding specific types of soda, and risk of hip fracture in postmenopausal women.

165 p an algorithm to predict the 5-year risk of hip fracture in postmenopausal women.

166 pes may be associated with increased risk of hip fracture in postmenopausal women; however, a clear m

167 There was a modest increased risk of hip fracture in the lowest compared with the middle quin

168 ve been shown to reduce spine, nonspine, and hip fractures in individuals at increased risk of fractu

169 rtile range, 0.57-2.34 years), there were 27 hip fractures in the alendronate group and 73 in the no-

170 egy, 12.8% of postmenopausal women sustained hip fractures in their remaining life (no screening, 18.

171 age milk consumption was not associated with hip fractures in women (RR = 1.00 per glass per day; 95%

172 in the risk of vertebral, nonvertebral, and hip fractures in women with osteoporosis.

173 ng concomitant osteoporosis medications) and hip fracture (in all patients).

174 Estimates of hip fracture incidence after age 65 years and postfractu

175 th policies should be strengthened to reduce hip fracture incidence and mortality.

176 Compared with 1-year hip fracture incidence in patients with cataract who did

177 Although both Medicare and survey-based hip fracture incidence showed the expected positive asso

178 d negative association with body mass index, hip fracture incidence was considerably underestimated b

179 g Medicare and survey-based sources to study hip fracture incidence.

180 Hip fracture is a potentially devastating condition for

181 ividuals, and to examine whether the risk of hip fracture is higher among HCV/HIV-coinfected persons,

182 tamin D [25(OH) vitamin D] concentration and hip fractures is unclear.

183 Hip fracture leads to pain and immobilization with compl

184 Among 42230 patients with hip fracture (mean [SD] age, 80.1 years [10.7], 70.5% wo

185 The prediction of centrally adjudicated hip fracture, measured by the area under the receiver op

186 endronate, risedronate, and estrogen prevent hip fractures more than placebo; the evidence for zoledr

187 congestive heart failure (CHF) (n = 92,377), hip fracture (n = 90,046), or colon cancer (n = 26,195)

188 More than 300,000 hip fractures occur each year in the United States.

189 ing a mean follow-up of 8.0 (1.7) years, 791 hip fractures occurred among women participating in the

190 Incident hip fractures occurring up to 10.7 y after baseline were

191 24 (3.5%) participants developed an incident hip fracture, of whom 413 (5.3%) died as a result.

192 to hip protector use, the incidence rate of hip fracture on protected vs unprotected hips did not di

193 The incidence rate of hip fracture on protected vs unprotected hips did not di

194 he relation of calcium intake to the risk of hip fracture on the basis of meta-analyses of cohort stu

195 older age and comorbidities associated with hip fracture on this increased perioperative risk is unk

196 trol patients were 7076 men without incident hip fracture, optimally matched at a 1:1 ratio to case p

197 f an adverse effect of high serum retinol on hip fracture or any interaction between retinol and 25-h

198 score of -2.5 or less, a history of spine or hip fracture, or a Fracture Risk Assessment Tool (FRAX)

199 t differences in risk of pulmonary embolism, hip fracture, or depression as a function of these three

200 ssociated with a significantly lower risk of hip fracture over a median of 1.32 years.

201 teoporotic fracture, as well as flavones for hip fracture (P < 0.05).

202 The road to recovery for hip fracture patients is long and most patients may not

203 Clinical trials in hip fracture patients with underlying cardiovascular dis

204 an BMD change was associated with 3.9 excess hip fractures per 100 persons.

205 , CKD was associated with increased risk for hip fracture, physiologic/metabolic derangements, and co

206 We compared a published hip fracture prediction model, which did not incorporate

207 difference based on bisphosphonate use, the hip fracture prediction score was included in multivaria

208 However, its role in hip fracture prevention is not established and high cons

209 hip fracture, according to the FRAX 10-year hip fracture probability.

210 A higher hip fracture rate was observed with lower intakes of alp

211 Norway has the highest hip fracture rates worldwide and a relatively high vitam

212 It has been hypothesized that hip-fracture rates are higher in developed than in devel

213 indications in the trauma setting including hip fracture, reduction of joint dislocation, wound debr

214 rogram with minimal supervision after formal hip fracture rehabilitation ends has not been establishe

215 male) and 5002 patients undergoing emergency hip fracture repair (mean [SD] age, 79.5 [11.8] years; 1

216 to be discharged with post-acute care after hip fracture repair (odds ratio, 0.65; 95% CI, 0.47-0.89

217 ption that Medicare beneficiaries undergoing hip fracture repair in CAHs had a higher risk of in-hosp

218 resection and patients undergoing emergency hip fracture repair successfully altered processes of ca

219 tomy, knee replacement, hip replacement, and hip fracture repair), mortality was equivalent between C

220 fe-saving procedures (eg, cancer surgery and hip fracture repair).

221 resection and patients undergoing emergency hip fracture repair.

222 stimate mechanical parameters that relate to hip fracture resistance by using MR images.

223 um 25(OH) vitamin D concentrations increased hip fracture risk (adjusted odds ratio for each 25-nmol/

224 association between total calcium intake and hip fracture risk [pooled risk ratio (RR) per 300 mg tot

225 ed FA consumption was associated with higher hip fracture risk [quartile 4 multivariate-adjusted haza

226 al prednisolone is associated with decreased hip fracture risk and adverse effects.

227 of total calcium intake in the prevention of hip fracture risk has not been well established.

228 Reduced hip fracture risk in both men (n = 1958) and women (n =

229 intake is not significantly associated with hip fracture risk in women or men.

230 As calculated hip fracture risk score was significantly associated wit

231 The increase in hip fracture risk was even more pronounced among those p

232 metric analyses that controlled confounding, hip fracture risk was not lower with moderate (e.g., tar

233 The increased hip fracture risk was persistent even years after vitami

234 mized controlled trials show no reduction in hip fracture risk with calcium supplementation, and an i

235 turated FA intake may significantly increase hip fracture risk, whereas monounsaturated and polyunsat

236 e not supported by cohort study findings for hip fracture risk.

237 sm contributing to the persistently elevated hip fracture risk.

238 ted with a significant 14% increased risk of hip fracture (RR: 1.14; 95% CI: 1.06, 1.23).

239 nts with DM (HRs for 1-unit increase in FRAX hip fracture score, 1.05; 95% CI, 1.03-1.07, for women w

240 itive scores, BMI, creatinine, arthritis and hip fracture, serum albumin and hemoglobin, and physical

241 st that the treatment of older patients with hip fractures should be organised as orthogeriatric care

242 months) of intervention models consisting of hip fracture-specific care in conjunction with managemen

243 Following hip fracture surgery (n = 319,804), 10,931 patients (3.4

244 the optimal time window in which to conduct hip fracture surgery before the risk of complications in

245 rospective cohort study of adults undergoing hip fracture surgery between April 1, 2009, and March 31

246 In a large cohort of French patients, hip fracture surgery compared with elective THR was asso

247 Although wait times for hip fracture surgery have been linked to mortality and a

248 ), and insufficient evidence from 1 trial on hip fracture surgery suggested more surgical-site bleedi

249 trated a higher risk of mortality (1.82% for hip fracture surgery vs 0.31% for elective THR; absolute

250 major postoperative complications (5.88% for hip fracture surgery vs 2.34% for elective THR; absolute

251 es of patients who underwent elective THR or hip fracture surgery was created using a multivariable l

252 Among adults undergoing hip fracture surgery, increased wait time was associated

253 cated greater use of regional anesthesia for hip fracture surgery.

254 0-2.62]; P < .001) among patients undergoing hip fracture surgery.

255 omorbidity compared with patients undergoing hip fracture surgery.

256 rtment visits for elders up to 2 years after hip-fracture surgery, above and beyond the effects of us

257 bin level was below 10 g per deciliter after hip-fracture surgery.

258 coronary artery disease, acute pancreatitis, hip fracture, syncope).

259 Patients with PA had a greater risk of hip fracture than the controls (HR = 1.74; 95% CI: 1.45-

260 ts for hip fracture (6,504 subjects with 139 hip fractures), the pooled RR between calcium and placeb

261 prospective cohort studies, 68,606 men, 214 hip fractures), the pooled RR per 300 mg total Ca/d was

262 For hip fracture, the estimated mean difference in T score f

263 had completed standard rehabilitation after hip fracture, the use of a home-based functionally orien

264 pective cohort studies, 170,991 women, 2,954 hip fractures), there was no association between total c

265 man who has experienced multiple falls and a hip fracture, this article, which focuses on community-l

266 ion of patients aged 70 years or more with a hip fracture to comprehensive geriatric care in a dedica

267 pulmonary disease) and a surgical diagnosis (hip fracture treated with arthroplasty) in 2010.

268 Qualitative similarities between hip fracture trends in different countries suggests vari

269 antify the burden of disease due to incident hip fracture using DALYs in prospective cohorts in the C

270 lity-adjusted life-years (DALYs) lost due to hip fractures using real-life follow-up cohort data.

271 Mean age at hip fracture was 85 years; 73% of fracture patients were

272 Hip fracture was adjudicated by a central review of radi

273 within 90 days after repair of a low-trauma hip fracture was associated with a reduction in the rate

274 less than or equal to -2.5, 10-year risk for hip fracture was greater than 3% (World Health Organizat

275 7 patients [10.6%]; P=0.04), and the risk of hip fracture was lower by 38% (41 of 2046 patients [2.0%

276 The unadjusted risk of hip fracture was lower in men with a high physical activ

277 ions of 25-hydroxyvitamin D and s-retinol on hip fracture was observed (P = 0.68).

278 Mr W, an older man who sustained a fall and hip fracture, we present evidence-based components of ca

279 The best predictors of hip fracture were entropy (P = .007; reproducibility coe

280 l associations between physical activity and hip fracture were estimated with 3 estimation methods: i

281 Incidence rates of hip fracture were lowest among uninfected persons (1.29

282 The associations between risk factors and hip fracture were similar in strength across BMI strata.

283 Selected factors that predicted hip fracture were then validated by 68,132 women who par

284 Adjusted odds ratios (ORs) of hip fractures were calculated using logistic regression

285 Hip fractures were confirmed by a medical record review;

286 Hip fractures were confirmed by central review.

287 al fractures were identified by self-report; hip fractures were confirmed by medical record review.

288 mean (SD) follow-up of 7.6 (1.7) years, 1132 hip fractures were identified among women participating

289 Hip fractures were identified from Medicare and follow-u

290 During follow-up, 1226 hip fractures were identified in women and 490 in men.

291 Patients with hip fractures were more likely than controls to have pre

292 , medication use, and other risk factors for hip fractures were reported on biennial questionnaires.

293 100 g/L within 3 days of surgery to repair a hip fracture, were eligible for enrolment.

294 rsing hip protector would reduce the risk of hip fracture when worn by nursing home residents.

295 ues that may arise in the older patient with hip fracture, while delivering evidence-based care compo

296 s prospectively explored the consequences of hip fracture with regard to discharge placement, functio

297 Denosumab reduced the risk of hip fracture, with a cumulative incidence of 0.7% in the

298 id not have cataract surgery, adjusted OR of hip fracture within 1 year after cataract surgery was 0.

299 s who had cataract surgery had lower odds of hip fracture within 1 year after surgery compared with p

300 Eleven factors predicted hip fracture within 5 years: age, self-reported health,